- Home
- MMLP vs ANVS Comparison
MMLP vs ANVS Comparison
Compare MMLP & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MMLP | ANVS |
|---|---|---|
| Founded | 2002 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil Refining/Marketing | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 102.3M | 111.3M |
| IPO Year | 2002 | 2020 |
Fundamental Metrics
Financial Performance| Metric | MMLP | ANVS |
|---|---|---|
| Price | $2.88 | $2.91 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $13.50 |
| AVG Volume (30 Days) | 21.2K | ★ 527.1K |
| Earning Date | 02-11-2026 | 11-12-2025 |
| Dividend Yield | ★ 0.69% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $713,263,000.00 | N/A |
| Revenue This Year | $4.19 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.21 | $1.11 |
| 52 Week High | $3.90 | $5.50 |
Technical Indicators
Market Signals| Indicator | MMLP | ANVS |
|---|---|---|
| Relative Strength Index (RSI) | 56.32 | 35.55 |
| Support Level | $2.75 | $2.98 |
| Resistance Level | $3.02 | $3.30 |
| Average True Range (ATR) | 0.18 | 0.27 |
| MACD | 0.01 | -0.09 |
| Stochastic Oscillator | 70.31 | 1.61 |
Price Performance
Historical ComparisonAbout MMLP Martin Midstream Partners L.P. Limited Partnership
Martin Midstream Partners LP has a diverse set of operations focused in the United States Gulf Coast region. The company's business lines include terminalling, processing, storage, and packaging services for petroleum products and by-products including the refining of naphthenic crude oil; land and marine transportation services for petroleum products and by-products, chemicals, and specialty products; sulfur and sulfur-based products processing, manufacturing, marketing and distribution; and natural gas liquids marketing, distribution and transportation services. Company operates in four segment Terminalling and storage, Transportation, Sulfur service and Specialty products segment. Majority of the revenue derived from Specialty products segment.
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.